Abstract
Empagliflozin belongs to a new class of anti diabetic drugs gliflozinů. Reduce blood glucose in patients with type 2 diabetes mellitus.
Long-term administration leads to a reduction in body weight and blood pressure.
Empagliflozin belongs to a new class of anti diabetic drugs gliflozinů. Reduce blood glucose in patients with type 2 diabetes mellitus.
Long-term administration leads to a reduction in body weight and blood pressure.